| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic
|
Poole-Wilson, Philip A
|
|
2003
|
87 |
2 |
p. 373-389
17 p.
|
artikel
|
| 2 |
Aldosterone as a target in congestive heart failure
|
Rajagopalan, Sanjay
|
|
2003
|
87 |
2 |
p. 441-457
17 p.
|
artikel
|
| 3 |
β-Blockers for heart failure: why, which, when, and where
|
Cleland, John G.F
|
|
2003
|
87 |
2 |
p. 339-371
33 p.
|
artikel
|
| 4 |
Digoxin remains useful in the management of chronic heart failure
|
William Dec, G
|
|
2003
|
87 |
2 |
p. 317-337
21 p.
|
artikel
|
| 5 |
Electrophysiological aids in congestive heart failure: supporting and synchronizing systole
|
Abraham, William T
|
|
2003
|
87 |
2 |
p. 509-521
13 p.
|
artikel
|
| 6 |
Genetic editing of dysfunctional myocardium
|
Hajjar, Roger J
|
|
2003
|
87 |
2 |
p. 553-567
15 p.
|
artikel
|
| 7 |
Index
|
|
|
2003
|
87 |
2 |
p. 579-587
9 p.
|
artikel
|
| 8 |
Metabolic modulation and optimization of energy consumption in heart failure
|
Ferrari, R.
|
|
2003
|
87 |
2 |
p. 493-507
15 p.
|
artikel
|
| 9 |
Pathophysiology of heart failure: identifying targets for pharmacotherapy
|
Katz, Arnold M
|
|
2003
|
87 |
2 |
p. 303-316
14 p.
|
artikel
|
| 10 |
Pharmacogenomics of congestive heart failure
|
Baliga, Ragavendra R
|
|
2003
|
87 |
2 |
p. 569-578
10 p.
|
artikel
|
| 11 |
Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics
|
Costello-Boerrigter, Lisa C
|
|
2003
|
87 |
2 |
p. 475-491
17 p.
|
artikel
|
| 12 |
Role of nonglycosidic inotropic agents: indications, ethics, and limitations
|
Chatterjee, Kanu
|
|
2003
|
87 |
2 |
p. 391-418
28 p.
|
artikel
|
| 13 |
Surgical restoration of the failing left ventricle
|
Westaby, Stephen
|
|
2003
|
87 |
2 |
p. 523-552
30 p.
|
artikel
|
| 14 |
Therapeutic options in heart failure
|
Baliga, Ragavendra R.
|
|
2003
|
87 |
2 |
p. xv-xvi
nvt p.
|
artikel
|
| 15 |
The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials?
|
Feldman, Arthur M
|
|
2003
|
87 |
2 |
p. 419-440
22 p.
|
artikel
|
| 16 |
Will endothelin receptor antagonists have a role in heart failure?
|
Spieker, Lukas E
|
|
2003
|
87 |
2 |
p. 459-474
16 p.
|
artikel
|
Tijdschrift beschrijving